Table 3.
Group | Outcome | N | Chi-Square | P | OR/BETA(d) | CI |
---|---|---|---|---|---|---|
Not engaged at 2 weeks | Any Cocaine Use | 159 | 2.25 | .13 | 0.66 | 0.38 1.14 |
% Days cocaine use | 159 | 0.10 | .75 | −0.13 (d= −.04) | −0.94 0.60 | |
Cocaine urine toxicology | 159 | 0.03 | .86 | 1.05 | 0.61 1.80 | |
Disengaged weeks 3–8 | Any Cocaine Use | 69 | 0.14 | .71 | 0.83 | 0.33 2.12 |
% Days cocaine | 69 | 2.02 | .16 | −0.84 (d= −.37) | −1.98 0.30 | |
Cocaine urine toxicology | 69 | 0.13 | .74 | 1.17 | 0.50 2.77 | |
Disengaged at weeks 2 and 8 | Any Cocaine Use | 84 | 0.85 | .36 | 1.48 | 0.64 3.40 |
% Days cocaine | 84 | 0.65 | .42 | 0.60 (d= .22) | −0.85 2.04 | |
Cocaine urine toxicology | 84 | 2.20 | .14 | 2.00 | 0.82 – 4.91 |
Treatment contrasts for MI-IOP vs. MI-PC coded as MI-IOP=1; MI-PC=0. Contrasts for MI-PC vs. no further outreach coded as MI-PC=1; no further outreach= 0.
Models include binary indicators of Site (VA versus nonVA), Study (P01 versus P60), and a nominal indicator for study month.
Effect sizes are indicated by Odds Ratios (OR) for the dichotomous outcomes and BETA and Cohen’s d values for continuous outcomes. CI= confidence intervals